Trial Profile
NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs NT 501 (Primary)
- Indications Optic nerve disorders
- Focus Adverse reactions
- 03 Nov 2014 New trial record